The Latest News From Leading Brands

Corporate and nonprofit news distributed by 3BL, including press releases, op/eds, multimedia, and the full range of stories that shape reputation.

Let Local Partners Lead
On June 11, Paraguay became the first country to be certified malaria-free by the World Health Organization (WHO) in more than 40 years. This is the latest in a series of triumphs for global efforts to combat infectious diseases. In December, the Global Polio Eradication Initiative reported a 99 percent reduction in annual polio cases since 1988. Between 2000 and 2016, the WHO estimates that new HIV infections fell 39 percent and, although still a leading cause of death worldwide, tuberculosis claimed 53 million fewer lives due to better diagnosis and treatment.
David Beckham Kicks Off Sixth Annual Sands for Singapore Charity Festival
Sands for Singapore is the annual charity festival organized by Marina Bay Sands to raise awareness of partner charities and raise funds for them through a series of events. David Beckham, Sands Global Ambassador and international sports star, announced the sixth annual festival will begin August 24 through August 26 at a special launch event.
Three Key Steps: Grow Your Business, Not Your Footprint
With the recent launch of our 2017 Sustainable Impact report, we reflect on how we are contributing to a more efficient, circular, and low-carbon economy and how we can continue to strengthen our business in 2018 and for the long-term. Here are three top learnings from our progress.
JetBlue March in NYC Disability Pride Parade in support of Reaching Blue Heights Initiatives
On July 15, JetBlue marched in the NYC Disability Pride Parade in support of JetBlue’s Reaching Blue Heights initiatives. Hosted by Disability Pride NYC, the parade’s purpose is to promote inclusion, awareness, and visibility of people with disabilities, and to redefine public perception of disability. This is JetBlue’s fourth time participating in the parade.
Novartis Renews Drug Donation of Egaten® (Triclabendazole) Until 2022, Reaffirming Its Commitment to the Fight Against Liver Fluke
Novartis reaffirms its commitment to the fight against liver fluke (fascioliasis), signing a renewed memorandum of understanding with the World Health Organization (WHO) to extend its drug donation for Egaten® (triclabendazole) until 2022. Egaten is currently the only treatment for fascioliasis recommended by the WHO and is on the WHO Model List of Essential Medicines.

Latest Campaigns

Collective Action

Cascale shares updates on its efforts and initiatives geared toward activating its ecosystem to develop and scale solutions that drive collective...

Responsible Business

We integrate responsible and sustainable practices in every aspect of our organization. Our products are created in ways that do not harm individuals...

SAP | Climate Action

Climate change is top of mind for government and business leaders worldwide who are committing to driving down greenhouse gas (GHG) emissions through...

SAP | Climate Action

Climate change is top of mind for government and business leaders worldwide who are committing to driving down greenhouse gas (GHG) emissions through...

Opportunity for All

At Trane Technologies, uplifting our communities and workforce is the key to our continued success. We focus on broadening access to education...

Health in Action

Our Prescription for a Better World framework is organized around three key pillars: building healthy communities (Health in Action), protecting the...

Healthy Spaces Podcast: Season 6

Healthy Spaces, a podcast by Trane Technologies, brings together engineers, innovators and industry leaders for bold conversations at the frontier of...